Pancreatic Cancer Research

ResearcherNingbo UniversityActive in the last 2 years

Dongjian Ying

ORCID-verified (high confidence, 0.95), identity_conf@1As of 7 November 2026

Matched on ORCID iD 0000-0001-6741-5591; OpenAlex author ID A5068552749. Sources: OpenAlex.

Their work

Papers
4 (first author 1, last author 2)
Trials
0
Grants
0
Labs led
1
Collaborators
8
Papers, trials and grants by year

2022: 1 paper · 2023: 2 papers · 2024: none · 2025: 1 paper

Papers 4

  1. Hypoxia-Challenged Pancreatic Adenocarcinoma Cell-Derived Exosomal circR3HCC1L Drives Tumor Growth Via Upregulating PKM2 Through Sequestering miR-873-5p. Co-author DOI 10.1007/s12033-024-01091-z↗
  2. Machine learning-based prediction of surgical benefit in borderline resectable and locally advanced pancreatic cancer. Last author DOI 10.1007/s00432-023-05071-9↗
  3. A population-based study of synchronous distant metastases and prognosis in patients with PDAC at initial diagnosis. Last author DOI 10.3389/fonc.2023.1087700↗
  4. LncRNA LINC01857 drives pancreatic adenocarcinoma progression via modulating miR-19a-3p/SMOC2. First author DOI 10.1016/j.clinsp.2022.100047↗

Closest collaborators

The 8 strongest of 8 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

  1. Xinhua Zhou · 2 shared papers, 2022–2025 · strength 0.39
  2. Yeting Lu · 2 shared papers, 2022–2025 · strength 0.39
  3. Leiming Zhang · 1 shared paper, 2023 · strength 0.26
  4. Leiming Zhang · 1 shared paper, 2023 · strength 0.24
  5. Luoluo Wang · 1 shared paper, 2025 · strength 0.22
  6. Xiang Wu · 1 shared paper, 2025 · strength 0.22
  7. Shuo Han · 1 shared paper, 2022 · strength 0.16
  8. Yuan Tian · 1 shared paper, 2022 · strength 0.16

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.